What AB 1587 does
An act to amend Section 4064 of the Business and Professions Code, relating to prescription drugs.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy. Existing law authorizes a pharmacist to, among other things, perform certain procedures or functions and furnish specified drugs. Existing law authorizes the refilling of a prescription for a dangerous drug without the authorization of the prescriber if the prescriber is unavailable to authorize the refill and, in the pharmacist’s professional judgment, failure to refill the prescription might interrupt the patient’s ongoing care and have a significant adverse effect on the patient’s well-being. Existing law requires a pharmacist to notify the prescriber, as specified, of any prescription refilled without their authorization.
This bill would only require a pharmacist to provide that notification if a prescriber is identified.
Summary from the Legislative Counsel's Digest of the chaptered text, July 13, 2026. Read the full text on leginfo.
How it got here
Assemblymember Ta introduced AB 1587 on January 15, 2026. The text was amended 1 time, and heard in 3 committee hearings before its final floor votes.
- Assembly Floor, April 23, 2026: 74 ayes, 0 noes.
- Senate Floor, June 25, 2026: 36 ayes, 0 noes.
Committee votes along the way:
- Assembly Business and Professions, April 7, 2026: Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar, 19-0.
- Assembly Appropriations, April 15, 2026: Do pass. To Consent Calendar., 13-0.
- Senate Business, Professions and Economic Development, June 8, 2026: Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar, 10-0.
Who supports and opposes AB 1587
The Senate Floor Analyses analysis dated June 24, 2026 lists 5 organizations in support and 0 in opposition. When Assembly Business and Professions first listed positions on April 3, 2026, the count was 4 in support and 0 opposed. By the Senate Floor Analyses analysis of June 24, 2026 it was 5 to 0.
In support: Biocom California; California Access Coalition; California Pharmacists Association; California Senior Legislature; Western Center on Law & Poverty.
Read the Senate Floor Analyses analysis.
What happens next
It was signed and chaptered on July 13, 2026 as Chapter 69, Statutes of 2026. Most provisions of a bill chaptered in this session take effect January 1.
The Governor can sign the bill, veto it, or let it become law without a signature. Until the decision, sign and veto request letters are the remaining channel, and the Department of Finance's enrolled bill report carries weight on anything with a fiscal effect. If signed, most provisions take effect January 1, and implementation moves to the agencies named in the bill.
What it means for pharmaceutical organizations
The work now is implementation: which agency writes the rules, when the comment period opens, and which obligations begin January 1. An organization that was not in the room for the bill can still shape the regulation, and the regulation is usually where the operating detail is settled.
The pharma group at Capitol Axis handles that for pharmaceutical clients.
Questions about AB 1587
What does AB 1587 do?
This bill would only require a pharmacist to provide that notification if a prescriber is identified.
Is AB 1587 law in California?
It was signed and chaptered on July 13, 2026 as Chapter 69, Statutes of 2026. Most provisions of a bill chaptered in this session take effect January 1.
Who supports and opposes AB 1587?
The Senate Floor Analyses analysis dated June 24, 2026 lists 5 organizations in support and 0 in opposition. Supporters include Biocom California; California Access Coalition; California Pharmacists Association.
What happens next with AB 1587?
The question now is implementation. The agencies named in the bill write the rules that decide what it means in practice, and those proceedings are open to comment.